☆ 4.8 Article

Gemini nanoparticles-based quadruple therapy (GNQT) achieved effective tumor immunotherapy by comprehensive regulation of tumor microenvironment

NANO TODAY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

Immunosuppressive microenvironment improvement and treatment of aggressive malignancy pancreatic ductal adenocarcinoma based on local administration of injectable hydrogel

Wenjia Zhang et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a devastating solid malignancy with a profuse fibrotic stromal reaction, hypoxia, and an immunosuppressive microenvironment. Immunotherapy has shown limited success in improving PDAC survival, so there is an urgent need for strategies that specifically target the immunosuppressive tumor microenvironment (TME) and immune-related therapeutic resistance. Photothermal immunotherapy, which combines local tumor hyperthermia with immune remodeling, has shown promise in PDAC treatment. This study develops an injectable peptide-based hydrogel integrated with near-infrared photothermal pigment and an immunomodulatory peptide for local PDAC administration and treatment, effectively inhibiting tumor recurrence and metastasis.

NANO TODAY (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Mild photothermal therapy boosts nanomedicine antitumor efficacy by disrupting DNA mechanics damage repair pathways and modulating tumor

Yuxuan Xiong et al.

Summary: Various PARPi have been approved for the treatment of breast cancers, but they are only effective for HR-deficient breast cancers. The abnormal micro-environment of breast cancers hinders drug delivery. This study used mesoporous polydopamine to deliver PARPi and a DNA-damaging drug, and demonstrated that local mild photothermal therapy could inhibit the HR repair pathway and repress cancer-associated fibroblasts, thereby enhancing the antitumor effect and improving drug delivery.

NANO TODAY (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity

Wencheng Wu et al.

Summary: This study reports a novel microbiotic nanomedicine LOD/TPZ@Lips-LA, which combines lactate oxidase (LOD) and prodrug tirapazamine (TPZ) loaded liposomes anchored on lactobacillus (LA) surface for chemotherapy-synergized antitumor immunity. The nanomedicine induces tumor cell apoptosis through in situ ROS generation and TPZ activation based on LA metabolism, resulting in strong immunogenic cell death (ICD). By regulating biomarker expression, it promotes anti-tumorigenic M1 polarization of innate tumor-associated macrophages and infiltration of adaptive cytotoxic CD8+ T cells, synergistically enhancing the tumor inhibition effects.

NANO TODAY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes

Jie Chen et al.

Summary: Obesity is a significant public health problem that needs to be urgently addressed. This study presents a potential effective strategy for the clinical treatment of obesity, using an adipocyte-targeting gene carrier combined with metformin to achieve body weight reduction and metabolic recovery.

SCIENCE CHINA-CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Improvement of radiotherapy with an ozone-carried liposome nano- system for synergizing cancer immune checkpoint blockade

Dan Zheng et al.

Summary: Radiotherapy synergizes with immune checkpoint blockade therapy by promoting immunogenic cell death. Researchers have developed an ozone-carrying liposome nano-system that can release ozone inside tumor cells, enhancing the anti-tumor efficacy of radiotherapy by inducing immunogenic cell death, releasing neoantigens, and relieving hypoxia symptoms.

NANO TODAY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthetic Helical Polypeptide as a Gene Transfection Enhancer

Zhiyu Yang et al.

Summary: This study developed a facile and effective strategy to construct polymeric gene delivery systems with high transfection efficiency. It was found that a cationic polypeptide with a stable alpha-helical conformation significantly improved the cellular uptake and endosomal escape of polymeric gene delivery systems, thereby enhancing transfection efficiency.

BIOMACROMOLECULES (2022)

添加到收藏夹

Article Engineering, Biomedical

A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy

Sijia Zhang et al.

Summary: As a representative of tumor immunotherapy, tumor vaccines can activate tumor-specific immune responses to inhibit tumor growth with the advantages of relatively low toxicity and high efficiency. This study developed a high-efficiency personalized nanovaccine by loading tumor-specific antigens with suitable carriers, which has a wide range of potential applications in tumor treatment.

BIOMATERIALS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

In situ vaccination and gene-medeiated PD-L1 blockade for enhanced tumor immunotherapy

Yingying Hu et al.

Summary: The researchers proposed a synergistic strategy combining in situ vaccination and gene-mediated anti-PD therapy, delivering CpG and pshPD-L1 genes using PEI as the carrier to form nanoparticles which showed synergistic antitumor efficacy in a mouse tumor model.

CHINESE CHEMICAL LETTERS (2021)

添加到收藏夹

Review Oncology

Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

Jim Middelburg et al.

Summary: CD3-bispecific antibody therapy is a rapidly developing field in immunotherapy, with approved use in hematological malignancies and ongoing research in solid tumors. However, treatment of solid tumors faces more challenges, including increased on-target off-tumor toxicities, sparse T-cell infiltration, and impaired T-cell quality due to an immunosuppressive tumor microenvironment, affecting the safety and efficacy of CD3-bispecific antibody therapy. Various combinatorial approaches are being explored to overcome these hurdles and improve the selectivity and effectiveness of the therapy.

CANCERS (2021)

添加到收藏夹

Review Oncology

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Deborah Blythe Doroshow et al.

Summary: PD-L1 expression is currently the best predictor of responsiveness to immune-checkpoint inhibitors, despite challenges in clinical use such as variability in different assays and cut-off points, as well as the lack of prospective comparisons with clinical outcomes. Nevertheless, several immunohistochemical assays have been approved for clinical use, with implications for pathology services and potential impacts on clinical outcomes. Comparison of FDA-approved PD-L1 assays, understanding of the varying implications of PD-L1 expression across different tumour types, and exploration of novel approaches to optimize its clinical utility are important topics for further research and practice.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Synergy of Immunostimulatory Genetherapy with Immune Checkpoint Blockade Motivates Immune Response to Eliminate Cancer

Ting Yu et al.

Summary: By utilizing the RGD-DMA/pCCL19-BMS-1 system, significant inhibition of tumor progression was achieved, along with induction of locally high concentrations of immunostimulatory cytokines at tumor sites, effectively reshaping the immunosuppressive TME.

ADVANCED FUNCTIONAL MATERIALS (2021)

添加到收藏夹

Article Engineering, Biomedical

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Suah Yang et al.

Summary: The construction of cancer-activated DOX prodrug nanoparticles provides a promising approach to enhance anticancer immune responses while minimizing side effects and systemic immunosuppression. These nanoparticles selectively target cancer cells, inducing cytotoxicity and immunogenic cell death, leading to increased response to checkpoint inhibitor immunotherapy.

BIOMATERIALS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy

Yaoqi Wang et al.

Summary: The study engineered sequential pH/redox-responsive nanoparticles to activate the immune microenvironment of tumors and lymph nodes, enhancing the antitumor immune response and providing a potential candidate for synergistic cancer chemo-immunotherapy.

NANO LETTERS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy

Jiwoong Choi et al.

Summary: Immune checkpoint blockade is a promising approach for cancer immunotherapy, but many patients do not respond due to the immunosuppressive tumor microenvironment. This study proposes visible-light-triggered prodrug nanoparticles (LT-NPs) to reverse the immunosuppressive tumor microenvironment and enhance checkpoint blockade immunotherapy, showing promising results in tumor models.

ACS NANO (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo

Huapan Fang et al.

Summary: While immunotherapy has shown promise as a cancer treatment, durable benefits are often limited by immune escape mechanisms. This study combines epigenetic regulation with gene therapy for immune checkpoint blockade to enhance anti-tumor effects and immune responses in vivo, providing a potential strategy for tumor treatment and prevention of relapse and metastasis.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells

Sanjay Varikuti et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Review Immunology

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

Paola De Cicco et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Engineering, Biomedical

Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger

Yingying Hu et al.

BIOMATERIALS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles

Jiayan Wu et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Cell Biology

Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade

Yang Liu et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Tumor microenvironment-oriented adaptive nanodrugs based on peptide self-assembly

Shukun Li et al.

CHEMICAL SCIENCE (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Hyaluronidase with pH-responsive Dextran Modification as an Adjuvant Nanomedicine for Enhanced Photodynamic-Immunotherapy of Cancer

Hairong Wang et al.

ADVANCED FUNCTIONAL MATERIALS (2019)

添加到收藏夹

Article Nanoscience & Nanotechnology

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators

Joao Conniot et al.

NATURE NANOTECHNOLOGY (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy

John-Michael Williford et al.

SCIENCE ADVANCES (2019)

添加到收藏夹

Article Engineering, Biomedical

Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase

Xiuwen Guan et al.

BIOMATERIALS (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Immune checkpoint inhibitors: recent progress and potential biomarkers

Pramod Darvin et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

添加到收藏夹

Review Hematology

CTLA-4: a moving target in immunotherapy

Behzad Rowshanravan et al.

BLOOD (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

添加到收藏夹

Review Oncology

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi et al.

NATURE REVIEWS CANCER (2017)

添加到收藏夹

Article Oncology

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Andrew Stiff et al.

CANCER RESEARCH (2016)

添加到收藏夹

Article Polymer Science

Polyglutamic acid based polyanionic shielding system for polycationic gene carriers

Jia-liang Xia et al.

CHINESE JOURNAL OF POLYMER SCIENCE (2016)

添加到收藏夹

Article Immunology

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Christina Pfirschke et al.

IMMUNITY (2016)

添加到收藏夹

Article Nanoscience & Nanotechnology

Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation

Haiyang Yu et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy

Hua Gong et al.

NANO LETTERS (2016)

添加到收藏夹

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

添加到收藏夹

Article Immunology

Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells

G. Hodge et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)

添加到收藏夹

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

添加到收藏夹

News Item Multidisciplinary Sciences

Cancer Immunotherapy

Jennifer Couzin-Frankel

SCIENCE (2013)

添加到收藏夹

Article Transplantation

The association between plasma uric acid and renal function decline in a Chinese population-based cohort

Luxia Zhang et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

添加到收藏夹

Article Oncology

Therapeutic Targeting of Hyaluronan in the Tumor Stroma

Anne Kultti et al.

Cancers (2012)

添加到收藏夹

Review Immunology

Coordinated regulation of myeloid cells by tumours

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2012)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

添加到收藏夹

Review Oncology

Altered hyaluronan biosynthesis in cancer progression

Naoki Itano et al.

SEMINARS IN CANCER BIOLOGY (2008)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management

Genzou Takemura et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2007)

添加到收藏夹

Article Urology & Nephrology

A role for uric acid in the progression of renal disease

DH Kang et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)

添加到收藏夹

Article Immunology

Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-α) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis

R Hussain et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.